ELISHA SHELTON: Open Payments
NPI 1477889400 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,533 in 43 payments from 15 companies in 2025. Trend: 2023 $428 · 2024 $5,975 · 2025 $2,533
Food & beverage: $1,283Travel & lodging: $1,250
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 17 | $1,938 |
| OPKO Pharmaceuticals, LLC | 5 | $94 |
| Fresenius USA Marketing, Inc. | 4 | $85 |
| Novartis Pharmaceuticals Corporation | 1 | $85 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $71 |
| Apellis Pharmaceuticals, Inc. | 2 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| Ardelyx, Inc. | 1 | $29 |
| Mallinckrodt Hospital Products Inc. | 1 | $26 |
| Aurinia Pharma U.S., Inc. | 1 | $25 |
Products named: RAYALDEE, VELPHORO, Vanrafia, Kerendia, Empaveli, JARDIANCE, IBSRELA, ACTHAR.
Industry payments across TX — which companies pay providers there.
